Inquis Medical develops the AVENTUS Precision Thrombectomy System, which provides a solution for the non-surgical removal of emboli and thrombi from blood vessels.

Inquis Medical

Inquis Medical, Inc. | 1,124 followers on LinkedIn. Inquis Medical, Inc. is a privately clinical stage medical device company based in Silicon Valley. Our company legacy is built on decades of developing, launching, and supporting novel, physician-tested medical devices that address unmet needs, with a long-lasting impact. Inquis Medical’s team is focused on improving the management of venous thromboembolic diseases.

Steve Miller

Erik Engelson

Eyal Aklivanh

Neuroscience | Machine Learning | Medical Devices

Diane Whitmer, Ph.D.

Inquis Medical, Inc.

Thank you to everyone who joined us at #VIVA24 and #TheVEINS24 ! A special thanks to Dr. Samuel Horr for his presentation on the AVENTUS Thrombectomy System. It was exciting to connect with all the experts dedicated to advancing VTE treatment and we look forward to making an even bigger splash at VIVA/VEINS next year!

Proud to announce that Inquis Medical has raised $40 million in Series B funding to advance our Aventus Thrombectomy System. Grateful for the support of our investors and the dedication of our team as we work to transform VTE care. https://lnkd.in/gjdVZQkT #InquisMedical #HealthcareInnovation #VTE #medtech #vascular #interventionalcardiology #interventionalradiology

Join us at #VIVA24 & #TheVEINS24 at the Wynn, Las Vegas, and discover the future of pulmonary embolism treatment! Don’t miss the AVENTUS Thrombectomy System presentation by Dr. Samuel Horr at the Blue Sky Breakfast Session at Lafleur 1 Ballrooms on Sunday, November 3rd, 2024.

Thank you to everyone who joined us at #TCT2024 ! Special thanks to Dr. Jun Li and University Hospitals Cleveland for the live case presentation of the AVENTUS Thrombectomy System. It was a great opportunity to highlight our innovative solution in action!

Congratulations to Dr. Christopher Laing, Dr. Henal Patel, and the dedicated team at Sutter Health for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Join us at the Endovascular Spotlight Room at #TCT2024 | October 30th for a live case presentation of the AVENTUS Thrombectomy System by Dr. Jun Li from University Hospitals Cleveland. Don’t miss this opportunity to see our innovative solution in action!

Congratulations to Dr. Joseph Ingrassia, Dr. Saurabh Joshi, and the dedicated team at Hartford Hospital for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

We're at #PERTConsortium2024 in Boston this week, where Dr. Jun Li, National Co-PI of the AVENTUS trial, will present an exciting case on the AVENTUS Thrombectomy System. If you’re at the conference, don’t miss the presentation at the PERT Poster Session. Date: September 12th Time: 5:00 - 6:00 PM ET We look forward to connecting with you there!

Congratulations to Dr. Bart Dolmatch, Dr. Fabio Komlos, and the dedicated team at El Camino Health for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS . #Cardiology #InterventionalCardiology

Congratulations to Dr. Saba Lahsaei and the dedicated team at NorthBay Medical Center for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Metric
Company Name	Inquis Medical
Symbol
MSH ID	COM:INQUISMEDICAL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	US
Stage
Employee Count
Website	inquismedical.com
LinkedIn	inquis-medical
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	968
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

INQU

COM:INQUISMEDICAL

Inquis Medical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue